MTOR and kidney angiomyolipoma: The decision to intervene in RAML depends on several clinical considerations including obvious symptoms or suspicion of malignant transformation.[1] Special consideration should be given to women who are pregnant or planning pregnancy, as the estrogen-sensitive nature of these tumors may lead to accelerated growth during gestation.[3,10] Various treatment modalities are available, ranging from minimally invasive approaches like arterial embolization and ablation to medical therapy with mammalian target of rapamycin (mTOR) inhibitors and definitive surgical resection.[3]